BOM (drug)
BOM, also known as 3,4,5,β-tetramethoxyphenethylamine or as β-methoxymescaline, is a drug of the phenethylamine, scaline, and BOx families. It is the β-methoxy derivative of mescaline.
Use and effects
In his book PiHKAL, Alexander Shulgin lists BOM's dose as greater than 200mg orally and its duration as unknown. Some indications of threshold central effects were observed at doses of 120 and 180mg orally, but higher doses were not explored. BOx drugs are known to be less potent than their non-β-substituted counterparts, so BOM might be active in the range of 200 to 400mg orally, but this remains unknown.
Chemistry
Synthesis
The chemical synthesis of BOM has been described.
Analogues
Analogues of BOM include β-hydroxymescaline, BOH, BOD, and DME, among others.
History
BOM was briefly mentioned by Abram Hoffer and Humphrey Osmond in their 1967 book The Hallucinogens. Subsequently, it was described in greater detail by Alexander Shulgin, Peyton Jacob III, and Darrell Lemaire in 1985. In addition, it was described in further detail by Shulgin in his 1991 book PiHKAL.
Legal status
Canada
BOM is not a controlled substance in Canada as of 2025.
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.